NovaBridge Biosciences (NBP) Non-Current Assets (2018 - 2026)

NovaBridge Biosciences (NBP) has reported Non-Current Assets for 8 consecutive years, with $43.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Non-Current Assets rose 19.49% year-over-year to $43.0 million; the TTM figure through Dec 2025 stood at $162.4 million (down 2.27% YoY), while the FY2025 annual figure was $43.0 million, up 19.49% from the prior year.
• Non-Current Assets slipped to $43.0 million in Q4 2025 per NBP's latest filing, from $44.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $209.5 million in Q4 2023 and bottomed at $23.3 million in Q2 2024.
• Historically, Non-Current Assets has averaged $98.1 million across 5 years, with a median of $44.6 million in 2025.
• Annual changes were most pronounced in 2021 — Non-Current Assets soared 186.85% — and 2024, when it tumbled 82.82%.
• NovaBridge Biosciences' Non-Current Assets stood at $188.8 million in 2021, then grew by 6.67% to $201.4 million in 2022, then rose by 4.01% to $209.5 million in 2023, then sank by 82.82% to $36.0 million in 2024, then advanced by 19.49% to $43.0 million in 2025.
• Business Quant data shows NBP's Non-Current Assets at $43.0 million in Q4 2025, $44.6 million in Q3 2025, and $39.1 million in Q2 2025.